source
- Veradermics soars on positive data for baldness treatmentThe results could support the first approval in decades for an oral medicine that can treat male pattern baldness, though the therapy will face competition from generics and over-the-counter medica…BioPharma Dive · 3mo ago↗ source
- Q&A: Intellia CEO talks first Phase 3 CRISPR readout and what’s nextIntellia Therapeutics reported this morning on the Phase 3 success of a gene editing treatment for hereditary angioedema, a disease that causes unpredictable, disfiguring and potentially dangerous…Endpoints · 3mo ago↗ source
- Thermo Fisher sells microbiology biz; Ligand to buy XOMAThermo Fisher Scientific sells microbiology business: Astorg, a European private equity firm, will acquire the unit for $1.075 billion. Thermo Fisher’s microbiology business is part of its specialt…